筛选
科学数据
统计数据
共检索到1条 ,权限内显示50条;
RAS-modification as a novel therapy for pulmonary indications in T2D
- 负责人：
- 关键词：
- Clinical and Experimental Therapeutics T2DM angiotensin(1-7) immune function lung fibrosis pulmonary indications
- DOI：
- doi:10.25549/usctheses-c40-350071
- 摘要：
- -identified insurance claims dataset to look at the association between RAS-modifying medications and the incidence of pulmonary complications. ? Methods
首页上一页1下一页尾页
